Next Article in Journal
Coming of Age in Canada: A Study of Population-Based Genetic Testing for Breast and Ovarian Cancer
Previous Article in Journal
Communication and Informed Consent ... a Story
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 24
Issue 5
10.3747/co.24.3825
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Timeliness of the Oncology Drug Review Process for Public Funding in Canada

by
T. Younis
1,* and
C. Skedgel
2,3
1
QEII Health Sciences Centre, Department of Medicine, Dalhousie University, Halifax, NS B3H 2Y9, Canada
2
Health Economics Group, Norwich Medical School, University of East Anglia, Norwich, Norfolk, UK
3
School of Pharmacy, Dalhousie University, Halifax, NS B3H 2Y9, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2017, 24(5), 279-281; https://doi.org/10.3747/co.24.3825
Submission received: 6 July 2017 / Revised: 4 August 2017 / Accepted: 2 September 2017 / Published: 1 October 2017

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

The oncology drug review process for public funding in Canada (Figure 1) encompasses both. [...]

Share and Cite

MDPI and ACS Style

Younis, T.; Skedgel, C. Timeliness of the Oncology Drug Review Process for Public Funding in Canada. Curr. Oncol. 2017, 24, 279-281. https://doi.org/10.3747/co.24.3825

AMA Style

Younis T, Skedgel C. Timeliness of the Oncology Drug Review Process for Public Funding in Canada. Current Oncology. 2017; 24(5):279-281. https://doi.org/10.3747/co.24.3825

Chicago/Turabian Style

Younis, T., and C. Skedgel. 2017. "Timeliness of the Oncology Drug Review Process for Public Funding in Canada" Current Oncology 24, no. 5: 279-281. https://doi.org/10.3747/co.24.3825

APA Style

Younis, T., & Skedgel, C. (2017). Timeliness of the Oncology Drug Review Process for Public Funding in Canada. Current Oncology, 24(5), 279-281. https://doi.org/10.3747/co.24.3825

Article Metrics

Back to TopTop